Knight Therapeutics Inc. (TSX:GUD)
Canada · Delayed Price · Currency is CAD 8.16
-0.20 (-2.39%)
May 26, 2026, 4:00 PM EST
Knight Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Knight Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $9.39. The average 1-year stock price forecast is 15.07% higher than the current stock price, while the lowest is $7.45 (-8.70%) and the highest is $12.00 (+47.06%).
Price Target: $9.39 (+15.07%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Knight Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Dec '25 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $9.50 | Buy | Initiates | $9.50 | +16.42% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $7.45 | Buy | Maintains | $7.45 | -8.70% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $8.50 → $9.50 | Buy | Maintains | $8.50 → $9.50 | +16.42% | May 8, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $11.00 → $12.00 | Buy | Maintains | $11.00 → $12.00 | +47.06% | May 8, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.